RE: Time for more top ups?7 Jun 2023 13:56
Aether - there's still a chance for STRIVE. Remember, the NIH passed us through P2 for ACTIV and then stopped it because of change in SOC and the need to completely redesign the trials.
If we were to get on something like that, 20p should be far exceeded and who knows, maybe The-Lockie will also get his 96p target.
Failing that, we have these clinical studies we'll be running. We haven't seen the details on that yet, but I'm hoping they'll offer some support to the SP. Of course, if we don't get a free PT, then a raise could well happen and who knows what the SP will do then... drop because of dilution, or rise because of having a P3 to go at and all the potential rewards that might offer...?
Big risk here. But potentially (still) big rewards.
AGM should be interesting...